Cell AI, a pioneering enterprise in human-machine interaction and bio-mimetic robotics, focuses on ​researching and producing advanced systems that bridge the gap between artificial intelligence and biological systems.

AI-powered virtual cells, based on advanced computational models, can significantly shorten the development cycle of innovative drugs, enhance scientific discovery capabilities, and expedite the research and development of novel pharmaceuticals.

Cell AI, a pioneering enterprise in the AI server and chip trade sector, leverages ​unique strategic partnerships to source and distribute ​cutting-edge AI servers and semiconductors globally, ensuring rapid access to emerging technologies.

Cell AI develops a closed-loop neural feedback system for thinking. Its AI model can dynamically adapt to small changes in the brain’s neural representation to achieve long-term and stable mind control functions.